Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of sIPV, DTaP, and MMR Vaccines in 18-Month-Old Infants
NCT04638985Phase 4Unknown
- Sponsor
- China National Biotec Group
- Start
- Nov 2020
- Primary completion
- Sep 2021
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Sabin Inactivated Poliovirus Vaccine (Vero Cell), diphtheria + tetanus + acellular pertussis vaccine, M-M-R II in poliomyelitis, diphtheria, Tetanus, pertussis, measles, sponsored by China National Biotec Group. Status: unknown.
02
Drugs
Sabin Inactivated Poliovirus Vaccine (Vero Cell)diphtheria + tetanus + acellular pertussis vaccineM-M-R II
03
Conditions
poliomyelitisdiphtheriaTetanuspertussismeasles
Beyond the preview
Go deeper on NCT04638985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04638985.